Ad
related to: KZR
Search results
Kezar (KZR) Falls 10% on Strategic Update, Reduces Workforce
Zacks via Yahoo Finance· 8 months agoKezar (KZR) falls 10% on the decision to channel resources to one clinical candidate as part of its...
Wall Street Analysts See an 82% Upside in Kezar Life Sciences, Inc. (KZR): Can the Stock Really Move...
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Kezar Life Sciences, Inc. (KZR) points to an 81.8% upside in...
Kezar (KZR) Doubles on Promising Kidney Disorder Study Data
Zacks via Yahoo Finance· 2 years agoShares of Kezar (KZR) surge more than 100% during after-hour trading on Jun 27, following a...
A Kezar Life Sciences, Inc. (NASDAQ:KZR) insider increased their holdings by 9.9% last year
Simply Wall St. via Yahoo Finance· 1 year agoInsiders were net buyers of Kezar Life Sciences, Inc.'s (NASDAQ:KZR ) stock during the past year....
Wells Fargo Beefs Up Kezar Life Price Target - Read Why
Benzinga via Yahoo Finance· 2 years agoWells Fargo reiterated its Overweight rating and raised its price target to $17 from $13 for Kezar...
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
Billionaire Israel Englander Pulls the Trigger on These 2 “Strong Buy” Stocks
TipRanks via Yahoo Finance· 2 years agoThe headlines have been busy recently about the heavy losses markets have taken this year, and that...
3 Biotech Stocks to Buy Before They Boom
InvestorPlace via Yahoo Finance· 2 years agoBiotech stocks have never really managed to recreate the success they had in 2020 amid the Covid-19 outbreak. For a second year in running, the sector is...
Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth
InvestorPlace via Yahoo Finance· 5 months agoIn the labyrinth of the stock market, discovering penny growth stocks often promises exhilarating...
Why Kezar Life Sciences Stock Is Crushing It Today
Motley Fool· 2 years agoShares of the clinical-stage biotech Kezar Life Sciences (NASDAQ: KZR) are soaring this morning following a positive mid-stage data readout for its lupus...
